Stock search

Ticker or company name

Compare stocks

Market: US

  • VTRSViatris
  • ZTSZoetis
  • BMYBristol Myers Squibb

Add stock

Ticker or company

Summary

VTRS
Viatris
$20,74Down −0,38%
Year: Up +91%
36/100Ratio would not consider buying
Open stock page
ZTS
Zoetis
$84,39Up +0,68%
Year: Down −31%
75/100Ratio would consider buying
Open stock page
BMY
Bristol Myers Squibb
$62,93Down −0,79%
Year: Up +30%
81/100Best scoreRatio would consider buying
Open stock page

Verdict

BMY has the best score (81). VTRS grows revenue the fastest. VTRS is the cheapest by forward P/E. ZTS has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckVTRS2 ✓ 1 — 4 ✕ZTS5 ✓ 2 — 1 ✕BMY5 ✓ 3 — 0 ✕
P/E vs its history—12,414,0
P/E vs industry—12,414,0
Forward P/En/a7,112,49,5
Revenue growth, YoY+4,3%+1,2%+4,2%
EPS growth, YoY—−1,0%+52,4%
Net marginn/a—26,1%18,5%
Net debt / EBITDA3,5n/a—n/a—
Free cash flow$2,11 bn$2,28 bn$9,29 bn
Share count over a year−1,4%−7,1%+0,7%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterVTRSTTMZTSTTMBMYTTMIndustry medianTTM
P/E TTM ↓n/aBest: 12,4Worst: 14,041,8
Forward P/E ↓Best: 7,1Worst: 12,49,512,4
PEG ↓n/a2,0−4,33,3
P/S TTM ↓Best: 1,6Worst: 3,42,63,4
EV/EBITDA ↓Worst: 12,611,8Best: 11,424,0
P/FCF ↓Best: 11,813,7Worst: 14,014,0

Price, %

  • VTRSn/a
  • ZTSn/a
  • BMYn/a

Returns

Best WorstNo mark — in between

PeriodVTRSZTSBMY
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

VTRSZTSBMY
Share of “buy”Best: 67%Worst: 41%41%
Beat the forecastBest: 4 of 4Worst: 2 of 4Best: 4 of 4
Average “surprise”+10,5%Worst: +3,2%Best: +16,6%
Insiders over 12 monthssales $1,09 msales $1,65 msales $2,53 m

Details are on each stock page.